Close
4

Seqens Seqens

X

Company profile for TALLC

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
TALLC is a new pre-clinical stage pharmaceutical company developing our proprietary CB2R agonist TA-A001, and pipeline candidates, as novel mechanism anti-inflammatories and analgesics. TALLC will focus first on meeting the demand for non-opioid, non-NSAID intravenous analgesics to manage postoperative pain. TA-A001's high potency, immediate onset, long duration of action and demonstrated synergies make it an ideal candi...
TALLC is a new pre-clinical stage pharmaceutical company developing our proprietary CB2R agonist TA-A001, and pipeline candidates, as novel mechanism anti-inflammatories and analgesics. TALLC will focus first on meeting the demand for non-opioid, non-NSAID intravenous analgesics to manage postoperative pain. TA-A001's high potency, immediate onset, long duration of action and demonstrated synergies make it an ideal candidate for the elective ambulatory surgery market without the fear of dependence or addiction. In parallel TALLC intends to demonstrate the value of TA-A001 as a treatment for acute and chronic eye pain.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
TALLC
Canada Flag
Country
Country
Canada
Address
Address
500 Cartier Blvd W Laval (Québec) H7V 5B7
Telephone
Telephone
514 883 3447

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY